Biomedical Research Scientists Endorse Specter/Feinstein/Hatch/Kennedy Cloning Compromise.
WASHINGTON -- In a letter sent to Senator Arlen Specter on Friday, twenty-seven leading biomedical research Biomedical research (or experimental medicine), in general simply known as medical research, is the basic research or applied research conducted to aid the body of knowledge in the field of medicine. scientists announced their strong support for S. 2439, the Human Cloning Although genes are recognized as influencing behavior and cognition, "genetically identical" does not mean altogether identical; identical twins, despite being natural human clones with near identical DNA, are separate people, with separate experiences and not altogether Prohibition Act of 2002 introduced by Senators Arlen Specter (R-PA), Dianne Feinstein Dianne Goldman Berman Feinstein (born June 22, 1933) is the senior U.S. Senator from California, having held office as a senator since 1992. She is a member of the Democratic Party. (D-CA), Orrin Hatch Orrin Grant Hatch (born March 22, 1934) is a Republican United States Senator from Utah, serving since 1977.
Hatch is a member of the U.S. Senate Committee on Finance, where he serves on the subcommittees on Energy, Natural Resources, and Infrastructure and Taxation and IRS (R-UT), and Edward Kennedy (D-MA). The scientists, who represent a wide variety of disciplines and academic institutions located throughout the United States, are board representatives of the Federation of American Societies for Experimental Biology (FASEB FASEB Federation of American Societies for Experimental Biology ).
The scientists expressed their support for a ban on human reproductive cloning Noun 1. human reproductive cloning - the reproductive cloning of a sentient human being; generally considered ethically unacceptable
reproductive cloning - making a full living copy of an organism; requires a surrogate mother , but reaffirmed their support for research using nuclear transplantation to produce stem cells, a procedure sometimes referred to as "therapeutic cloning therapeutic cloning
A procedure in which damaged tissues or organs are repaired or replaced with genetically identical cells that originate from undifferentiated stem cells. ." In the letter, the scientists discussed the benefits of nuclear transplantation research over other human embryonic stem cell Embryonic stem cells (ES cells) are stem cells derived from the inner cell mass of an early stage embryo known as a blastocyst. Human embryos reach the blastocyst stage 4-5 days post fertilization, at which time they consist of 50-150 cells.
ES cells are pluripotent. research.
The undersigned un·der·signed
1. Having signatures or a signature at the bottom or end. Used of documents.
2. Signed or having signed at the bottom or end of a document: sent the following letter, dated May 7, to The Honorable Arlen Specter:
As board members of 21 scientific societies represented by the Federation of American Societies for Experimental Biology (FASEB), we are writing to thank you for introducing S. 2439, the Human Cloning Prohibition Act of 2002.
We strongly support your efforts to ban human reproductive cloning and to permit research involving nuclear transplantation to produce stem cells, under appropriate ethical guidelines.
We believe that human embryonic stem cell research offers significant therapeutic promise for treating a host of diseases and debilitating de·bil·i·tat·ing
Causing a loss of strength or energy.
Weakening, or reducing the strength of.
Mentioned in: Stress Reduction disorders afflicting millions of Americans. While we are grateful to the President for his decision last year to allow research on a qualified number of human embryonic stem cell lines, the usefulness of these cell lines is limited by a number of factors that can be addressed through nuclear transplantation. First, nuclear transplantation research will enable the production of embryonic stem cell lines that more fully represent the genetic diversity of the U.S. population. Second, nuclear transplantation will enable scientists to identify and understand the interplay of heritable her·i·ta·ble
1. Capable of being passed from one generation to the next; hereditary.
2. Capable of inheriting or taking by inheritance. genetic factors that gives rise to diseases such as diabetes or Alzheimer's. Third, in the field of cancer research, nuclear transplantation will enable scientists to examine a variety of mutations that produced certain cancer cells. Finally, nuclear transplantation research raises the hope that, in the future, patients will receive therapies that are individually developed for them -- dramatically reducing the risk of immune rejection.
For more than a half-century, America's best scientists have produced spectacular medical advances. The exciting new field of regenerative medicine now offers substantial potential for greater breakthroughs. S. 2439 would assure that this vital research is conducted under appropriate ethical guidelines -- and that Americans have early access to its therapeutic benefits.
Once again, on behalf of FASEB's 60,000 member scientists, we thank you for advancing biomedical research and strongly endorse S. 2439.
Robert R. Rich, MD President, FASEB American Association of Immunologists Emory University School of Medicine Atlanta, GA Leo Furcht, MD American Association of Investigative Pathology University of Minnesota Medical School Minneapolis, MN Marlene Cohen, PhD American Society for Pharmacology and Experimental Therapeutics Lilly Research Laboratories Indianapolis, IN Richard G. Lynch, MD American Society for Investigative Pathology University of Iowa College of Medicine Iowa City, IA Barbara A. Horwitz, MD The American Physiological Society University of California - Davis Davis, CA Janet Hall, MD The Endocrine Society Massachusetts General Hospital, Harvard Medical School Boston, MA Gerald F. DiBona, MD American Physiological Society University of Iowa College of Medicine Iowa City, IA Michael Conn, PhD The Endocrine Society Oregon Health and Science University Portland, OR Karen L. Bennett Society for Developmental Biology University of Missouri Columbia, MO Richard Marchase, PhD American Association of Anatomists University of Alabama - Birmingham Birmingham, AL Robert D. Wells, PhD American Society for Biochemistry & Molecular Biology Texas A&M University Houston, TX Mary J.C. Hendrix, PhD FASEB Past President American Association of Anatomists The University of Iowa Iowa City, IA Alfred H. Merrill, PhD American Society for Nutritional Sciences Georgia Institute of Technology Atlanta, GA James C. Rose, PhD Society for Gynecologic Investigation Wake Forest University Winston Salem, NC Roger A. Sunde, PhD American Society for Nutritional Sciences University of Missouri Columbia, MO Jerry Mitchell, MD, PhD American Society for Pharmacology and Experimental Therapeutics Baylor College of Medicine Houston, TX C. Robert Matthews, PhD The Protein Society University of Massachusetts Medical School Worcester, MA Garry Cutting, MD The American Society for Human Genetics Johns Hopkins University Baltimore, MD John A. Smith, MD, PhD American Peptide Society University of Alabama, Birmingham Birmingham, AL David Valle, MD American Society for Human Genetics Johns Hopkins University Baltimore, MD David G. Kaufman, MD, PhD FASEB Past-President University of North Carolina Chapel Hill, NC Robert D. Koos, PhD Society for the Study of Reproduction University of Maryland Baltimore, MD Michael A. Levine, MD American Society for Bone & Mineral Research Johns Hopkins University Baltimore, MD John M. DeSesso, PhD Teratology Society Mitretek Systems Falls Church, VA Paul W. Kincade, PhD The American Association of Immunologists Oklahoma Medical Research Foundation Oklahoma City, OK Steven Teitelbaum, MD FASEB President-Elect American Society for Bone & Mineral Research Washington University School of Medicine St. Louis, MO Bettie Sue Masters, PhD American Society for Biochemistry & Molecular Biology University of Texas Health Science Center San Antonio, TX
MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X68564602
Contact: Pat White of the Federation of American Societies for Experimental Biology, +1-202-543-1155